NCT05886205View on ClinicalTrials.gov

Induced Pluripotent Stem Cell Derived Exosomes Nasal Drops for the Treatment of Refractory Focal Epilepsy

EARLY_PHASE1RecruitingINTERVENTIONAL

Enrollment

34

Participants

Timeline

Start Date

June 5, 2023

Primary Completion Date

June 13, 2025

Study Completion Date

November 13, 2025

Conditions

Refractory Focal Epilepsy

Interventions

DRUG

iPSC-Exos

iPSC-Exos were administrated for nasal drip, bid for 12 weeks.

Trial Locations (1)

100730

RECRUITING

Peking Union Medical College Hospital, Beijing

Sponsors

Collaborators (1)

Guidon Pharmaceutics Ltd.

All Listed Sponsors

collaborator

Guidon Pharmaceutics Ltd.

INDUSTRY

lead

Peking Union Medical College Hospital

OTHER